Global Non-Invasive Liquid Biopsy Market, 2021-2027

February 2022 | 78 pages | ID: GE29317B1607EN
Gen Consulting Company

Abstracts

A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. According to market research study published by Gen Consulting Company, the global non-invasive liquid biopsy market stood at around USD 1,467 million in 2020 and is projected to rise to a worth of USD 4,072 million by 2027 end, thereby garnering a CAGR of 15.7% during 2021-2027.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global non-invasive liquid biopsy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The non-invasive liquid biopsy market is segmented on the basis of product, technology, sample, application, and application. The non-invasive liquid biopsy market is segmented as below:

By product:

• kits and assays
• services

By technology:

• polymerase chain reaction (PCR)
• sequencing
• microarray
• others

By sample:

• faeces
• urine
• saliva
• others

By application:

• application
• oncology
• reproductive health
• metabolic disorders
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Non-Invasive Liquid Biopsy Market, including Analytik Jena AG, EXACT Sciences Corporation, Exosome Diagnostics, Inc. (Bio-Techne Corporation), Lonza Group AG (Exosomics Siena S.p.A), MDxHealth BV, Merck KGaA, OraSure Technologies, Inc., PerkinElmer, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global non-invasive liquid biopsy market.
• To classify and forecast the global non-invasive liquid biopsy market based on product, technology, sample, application, and application.
• To identify drivers and challenges for the global non-invasive liquid biopsy market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global non-invasive liquid biopsy market.
• To identify and analyze the profile of leading players operating in the global non-invasive liquid biopsy market.

Why Choose This Report

• Gain a reliable outlook of the global non-invasive liquid biopsy market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR NON-INVASIVE LIQUID BIOPSY BY PRODUCT

5.1 Kits and assays
  5.1.1 Market size and forecast
5.2 Services
  5.2.1 Market size and forecast

PART 6. GLOBAL MARKET FOR NON-INVASIVE LIQUID BIOPSY BY TECHNOLOGY

6.1 Polymerase chain reaction (PCR)
  6.1.1 Market size and forecast
6.2 Sequencing
  6.2.1 Market size and forecast
6.3 Microarray
  6.3.1 Market size and forecast
6.4 Others
  6.4.1 Market size and forecast

PART 7. GLOBAL MARKET FOR NON-INVASIVE LIQUID BIOPSY BY SAMPLE

7.1 Faeces
  7.1.1 Market size and forecast
7.2 Urine
  7.2.1 Market size and forecast
7.3 Saliva
  7.3.1 Market size and forecast
7.4 Others
  7.4.1 Market size and forecast

PART 8. GLOBAL MARKET FOR NON-INVASIVE LIQUID BIOPSY BY APPLICATION

8.1 Oncology
  8.1.1 Market size and forecast
8.2 Reproductive health
  8.2.1 Market size and forecast
8.3 Metabolic disorders
  8.3.1 Market size and forecast
8.4 Others
  8.4.1 Market size and forecast

PART 9. GLOBAL MARKET FOR NON-INVASIVE LIQUID BIOPSY BY REGION

9.1 Asia Pacific
  9.1.1 Market size and forecast
9.2 Europe
  9.2.1 Market size and forecast
9.3 North America
  9.3.1 Market size and forecast
9.4 Rest of the World (RoW)
  9.4.1 Market size and forecast

PART 10. KEY COMPETITOR PROFILES

10.1 Analytik Jena AG
10.2 EXACT Sciences Corporation
10.3 Exosome Diagnostics, Inc. (Bio-Techne Corporation)
10.4 Lonza Group AG (Exosomics Siena S.p.A)
10.5 MDxHealth BV
10.6 Merck KGaA
10.7 OraSure Technologies, Inc.
10.8 PerkinElmer, Inc.
10.9 QIAGEN N.V.
10.10 Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY